Role and Limits of COVID-19 Vaccines in the Delicate Transition from Pandemic Mitigation to Endemic Control

Jean-Nicolas Tournier,Frédéric Tangy,Fabrice Simon,Vincent Pommier de Santi,Marie Mura

doi:10.3390/vaccines10091555

Role and Limits of COVID-19 Vaccines in the Delicate Transition from Pandemic Mitigation to Endemic Control

Jean-Nicolas Tournier, Frédéric Tangy

Open Access

https://doi.org/10.3390/vaccines10091555

Copy DOI

Journal: Vaccines	Publication Date: Sep 18, 2022
Citations: 3	License type: CC BY 4.0

Affiliation: Institut Pasteur, Institut de Médecine Tropicale du Service de Santé des Armées, HIA du Val-de-Grâce à Paris, Hôpital Laveran, Centre for Research in Epidemiology and Population Health

#Critical Point Of View #Virological Evolution + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

The recent surge of COVID-19 related to the Omicron variant emergence has thrown a harsh light upon epidemic control in the near future. This should lead the scientific and medical community to question the long-term vaccine strategy for SARS-CoV-2 control. We provide here a critical point of view regarding the virological evolution, epidemiological aspects, and immunological drivers for COVID-19 control, including a vaccination strategy. Overall, we need more innovations in vaccine development to reduce the COVID-19 burden long term. The most adequate answer might be better cooperation between universities, biotech and pharmaceutical companies

Full Text